Articles with public access mandates - Javier ArbizuLearn more
Not available anywhere: 5
Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: patterns of integration in therapy planning
J Arbizu, S Tejada, JM Marti-Climent, R Diez-Valle, E Prieto, G Quincoces, ...
European journal of nuclear medicine and molecular imaging 39, 771-781, 2012
Mandates: Government of Spain
Plasma Aβ42/40 ratio detects early stages of Alzheimer’s disease and correlates with CSF and neuroimaging biomarkers in the AB255 study
V Perez-Grijalba, J Romero, P Pesini, L Sarasa, I Monleon, I San-Jose, ...
The journal of prevention of Alzheimer's disease 6, 34-41, 2019
Mandates: Government of Spain
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease dementia
J Arbizu, E Prieto, P Martínez-Lage, JM Martí-Climent, M García-Granero, ...
European journal of nuclear medicine and molecular imaging 40, 1394-1405, 2013
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Brain PET imaging optimization with time of flight and point spread function modelling
E Prieto, JM Martí-Climent, V Morán, L Sancho, B Barbés, J Arbizu, ...
Physica Medica 31 (8), 948-955, 2015
Mandates: Government of Spain
Aportación del tiempo de vuelo y de la modelización de la respuesta a una fuente puntual a las características de funcionamiento del tomógrafo PET/TAC Biograph mCT
JM Martí-Climent, E Prieto, I Domínguez-Prado, MJ García-Velloso, ...
Revista Española de Medicina Nuclear e Imagen Molecular 32 (1), 13-21, 2013
Mandates: Government of Spain
Available somewhere: 21
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
G Chételat, J Arbizu, H Barthel, V Garibotto, I Law, S Morbelli, ...
The Lancet Neurology 19 (11), 951-962, 2020
Mandates: Swiss National Science Foundation, US National Institutes of Health …
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
S Morbelli, G Esposito, J Arbizu, H Barthel, R Boellaard, NI Bohnen, ...
European journal of nuclear medicine and molecular imaging 47, 1885-1912, 2020
Mandates: US National Institutes of Health
Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process
R Gonzalez-Redondo, D García-García, P Clavero, C Gasca-Salas, ...
Brain 137 (8), 2356-2367, 2014
Mandates: Government of Spain
Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease
D Garcia-Garcia, P Clavero, C Gasca Salas, I Lamet, J Arbizu, ...
European journal of nuclear medicine and molecular imaging 39, 1767-1777, 2012
Mandates: Government of Spain
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
Z Walker, F Gandolfo, S Orini, V Garibotto, F Agosta, J Arbizu, F Bouwman, ...
European journal of nuclear medicine and molecular imaging 45, 1534-1545, 2018
Mandates: European Commission, Government of Italy
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission …
F Nobili, J Arbizu, F Bouwman, A Drzezga, F Agosta, P Nestor, Z Walker, ...
European journal of neurology 25 (10), 1201-1217, 2018
Mandates: European Commission, Government of Italy
Clinical utility of FDG-PET for the clinical diagnosis in MCI
J Arbizu, C Festari, D Altomare, Z Walker, F Bouwman, J Rivolta, S Orini, ...
European journal of nuclear medicine and molecular imaging 45, 1497-1508, 2018
Mandates: European Commission, Government of Italy
Decreased carbon-11-flumazenil binding in early Alzheimer’s disease
B Pascual, E Prieto, J Arbizu, JM Marti-Climent, I Penuelas, G Quincoces, ...
Brain 135 (9), 2817-2825, 2012
Mandates: Government of Spain
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
V Pérez-Grijalba, J Arbizu, J Romero, E Prieto, P Pesini, L Sarasa, ...
Alzheimer's research & therapy 11, 1-9, 2019
Mandates: Government of Spain
PET optimization for improved assessment and accurate quantification of 90Y‐microsphere biodistribution after radioembolization
JM Martí‐Climent, E Prieto, C Elosúa, M Rodríguez‐Fraile, ...
Medical physics 41 (9), 092503, 2014
Mandates: Government of Spain
Contribution of time of flight and point spread function modeling to the performance characteristics of the PET/CT Biograph mCT scanner
JM Martí-Climent, E Prieto, I Domínguez-Prado, MJ García-Velloso, ...
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 32 …, 2013
Mandates: Government of Spain
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
F Bouwman, S Orini, F Gandolfo, D Altomare, C Festari, F Agosta, J Arbizu, ...
European journal of nuclear medicine and molecular imaging 45, 1526-1533, 2018
Mandates: European Commission, Government of Italy
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
F Agosta, D Altomare, C Festari, S Orini, F Gandolfo, M Boccardi, J Arbizu, ...
European journal of nuclear medicine and molecular imaging 45, 1546-1556, 2018
Mandates: European Commission, Government of Italy
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)
A Chincarini, E Peira, S Morbelli, M Pardini, M Bauckneht, J Arbizu, ...
NeuroImage: Clinical 23, 101846, 2019
Mandates: Swiss National Science Foundation
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
M Boccardi, C Festari, D Altomare, F Gandolfo, S Orini, F Nobili, ...
European journal of nuclear medicine and molecular imaging 45, 1470-1486, 2018
Mandates: Federal Ministry of Education and Research, Germany
Publication and funding information is determined automatically by a computer program